We are live on ! Find out more
DRMA icon

Dermata Therapeutics
DRMA

7 hedge funds and large institutions have $129K invested in Dermata Therapeutics in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$81.3K
2
+$57.8K
3
+$33.7K
4
MA
MCF Advisors
Kentucky
+$2.92K
5
Citigroup
Citigroup
New York
+$2

Top Sellers

1
-$39.4K
2
-$8.02K
3
-$5.57K
4
TRCT
Tower Research Capital (TRC)
New York
-$2.16K
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.61K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$58.5K
UBS Group
2
UBS Group
Switzerland
$43.1K
WF
3
Welch & Forbes
Massachusetts
$24.2K
MA
4
MCF Advisors
Kentucky
$2.1K
TRCT
5
Tower Research Capital (TRC)
New York
$866
SS
6
SBI Securities
Japan
$122
Citigroup
7
Citigroup
New York
$1
CS
8
Clear Street
New York
–
Bank of America
9
Bank of America
North Carolina
–
Barclays
10
Barclays
United Kingdom
–
JP Morgan Chase
11
JP Morgan Chase
New York
–